Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer
<p>Abstract</p> <p>Background</p> <p>Most bladder cancer patients experience lymphatic metastasis in the course of disease progression, yet the relationship between lymphangiogenesis and lymphatic metastasis is not well known. The aim of this study is to elucidate under...
Main Authors: | Kim Wun-Jae, Kim Injune, Heston Warren, Alitalo Kari, Schwendener Reto A, Kim Min-Ju, Kim Chan, Yang Hanseul, Koh Gou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-04-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/10/1/36 |
Similar Items
-
Long noncoding RNA BLACAT2 promotes bladder cancer–associated lymphangiogenesis and lymphatic metastasis
by: Wang He, et al.
Published: (2022-08-01) -
Lymphatic markers, tumour lymphangiogenesis and lymph node metastasis.
by: Jackson, D
Published: (2007) -
ETV4 Mediated Tumor‐Associated Neutrophil Infiltration Facilitates Lymphangiogenesis and Lymphatic Metastasis of Bladder Cancer
by: Qiang Zhang, et al.
Published: (2023-04-01) -
Lymphatics and Lymphangiogenesis in the Eye
by: Shintaro Nakao, et al.
Published: (2012-01-01) -
PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis.
by: Cao, R, et al.
Published: (2004)